CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients
Regulatory T cells (Tregs) are key mediators of immune tolerance and feature prominently in
cancer. Depletion of CD25+ FoxP3+ Tregs in vivo may promote T cell cancer …
cancer. Depletion of CD25+ FoxP3+ Tregs in vivo may promote T cell cancer …
[HTML][HTML] CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
AJ Rech, R Mick, S Martin, A Recio… - Science translational …, 2012 - ncbi.nlm.nih.gov
Regulatory T cells (T regs) are key mediators of immune tolerance and feature prominently
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients.
AJ Rech, R Mick, S Martin, A Recio… - Science Translational …, 2012 - europepmc.org
Regulatory T cells (T regs) are key mediators of immune tolerance and feature prominently
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
[引用][C] CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
AJ Rech, R Mick, S Martin, A Recio, NA Aqui… - Science Translational …, 2012 - cir.nii.ac.jp
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with
Immunotherapy in Cancer Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Immunotherapy in Cancer Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients.
AJ Rech, R Mick, S Martin, A Recio… - Science …, 2012 - search.ebscohost.com
Regulatory T cells (T< sub> regs) are key mediators of immune tolerance and feature
prominently in cancer. Depletion of CD25< sup>+ FoxP3< sup>+ Tregs in vivo may promote …
prominently in cancer. Depletion of CD25< sup>+ FoxP3< sup>+ Tregs in vivo may promote …
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients
AJ Rech, R Mick, S Martin, A Recio… - Science …, 2012 - pubmed.ncbi.nlm.nih.gov
Regulatory T cells (T (regs)) are key mediators of immune tolerance and feature prominently
in cancer. Depletion of CD25 (+) FoxP3 (+) T (regs) in vivo may promote T cell cancer …
in cancer. Depletion of CD25 (+) FoxP3 (+) T (regs) in vivo may promote T cell cancer …
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients
AJ Rech, R Mick, S Martin, A Recio… - Science …, 2012 - pure.johnshopkins.edu
Regulatory T cells (T regs) are key mediators of immune tolerance and feature prominently
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients
AJ Rech, R Mick, S Martin, A Recio, NA Aqui… - Science Translational …, 2012 - pure.psu.edu
Regulatory T cells (T regs) are key mediators of immune tolerance and feature prominently
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients.
AJ Rech, R Mick, S Martin, A Recio… - Science Translational …, 2012 - europepmc.org
Regulatory T cells (T regs) are key mediators of immune tolerance and feature prominently
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …
in cancer. Depletion of CD25+ FoxP3+ T regs in vivo may promote T cell cancer …